Niraparib
NCT05406700
Massachusetts General Hospital · Phase 1 · Active, not recruiting · Enrollment 16
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
Disease Pipeline Tools IDH-mutant glioma
IDH-mutant glioma
Programs, trials, and reported response and survival for IDH-mutant glioma.
Niraparib
Massachusetts General Hospital · Phase 1 · Active, not recruiting · Enrollment 16
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.